Racemorphan
Not to be confused with Morphan.
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number |
297-90-5 5985-35-3 (HBr) |
PubChem (CID) | 3918 |
ChemSpider | 3781 |
UNII | V7R79HN3XD Y |
ChEMBL | CHEMBL20803 |
ECHA InfoCard | 100.005.499 |
Chemical and physical data | |
Formula | C17H23NO |
Molar mass | 257.37 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Racemorphan, or morphanol, is the racemic mixture of the two stereoisomers of 17-methylmorphinan-3-ol, each with differing pharmacology and effects:
- Dextrorphan - an antitussive and dissociative hallucinogen (NMDA receptor antagonist)
- Levorphanol - an opioid analgesic
Racemorphan itself is under international control per the Single Convention on Narcotic Drugs 1961 and is therefore listed as a Schedule II Narcotic controlled substance in the US Controlled Substances Act 1970; it has an ACSCN of 9733 and in 2014 it had an aggregate annual manufacturing quota of zero. [1] The salts in use are hydrobromide (free base conversion ratio 0.741), hydrochloride (0.876), and tartrate (0.632).
See also
References
Receptor (ligands) |
| ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (blockers) |
| ||||||||||||||||||||||||||||||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||||||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||||||||||||||||||
See also: GABAergics • GHBergics • Glycinergics |
MOR |
|
---|---|
DOR |
|
KOR |
|
NOP |
|
Unsorted |
|
Others |
|
See also: Peptide receptor modulators |
Agonists |
|
---|---|
Antagonists |
|
Unknown / unsorted |
|
This article is issued from Wikipedia - version of the 6/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.